It’s been less than a year since Nuvectra Medical spun-off from Greatbatch Inc. (now Integer), and in that time Nuvectra has built a sales organization and laid the organizational foundation to become a, multi-indication neurostimulation company.
Anne Staylor
Recent Posts
2 min read
Nuvectra: Positioned For Growth In Neuromodulation
Topics:
Neuro Therapies
Continue Reading
3 min read
Finding the Sweet Spot: Medtronic’s Growth Strategies for Spinal Cord Stimulation
In an interview with BioMedGPS, Medtronic’s Marshall Stanton, MD discussed the Company’s strategies for gaining back market share in spinal cord stimulation and ongoing efforts to find the sweet spot in treating chronic intractable pain.
Topics:
Neuro Therapies
Continue Reading
2 min read
BioMedGPS Announces Expansion of SmartTRAK Business Intelligence to the Neuromodulation and Neurovascular Markets
January 25, 2017 02:46 PM Eastern Standard Time
IRVINE, Calif.--(BUSINESS WIRE)--BioMedGPS, the leading provider of real-time business analytics and analysis of the orthopedic/spine, wound care and regenerative medicine markets, announces expanded coverage of SmartTRAK Business Intelligence to the Neuro Therapies market with the introduction of SmartTRAK Neuromodulation and SmartTRAK Neurovascularmodules.
Topics:
Neuro Therapies
Continue Reading
2 min read
Podcast: Medtronic's Strategy For Restorative Therapies Group’s Newly Formed Brain Therapies Division
An Interview with Medtronic’s Brett Wall, Sr. VP and President, Brain Therapies and Scott Hutton, VP and General Manager, Neurosurgery
